Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors-Reference-Cited by-同舟云学术

Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors

Published:2004-05 Issue:2 Volume:44 Page:193-198
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Bazhin Alexandr V,Savchenko Marina S,Shifrina Olga N,Demoura Sofia A,Chikina Svetlana Yu,Jaques Gabriele,Kogan Eugenia A,Chuchalin Alexandr G,Philippov Pavel P

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Cancer-associated retinopathy;Thirkill;Arch. Ophtalmol.,1987

2. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy;Polans;J. Cell Biol.,1991

3. New 26kDa protein specific for photoreceptor cells, capable of binding to immobilized delipidated rhodopsin;Dizhoor;Biokhimia (Moscow),1991

4. Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase;Dizhoor;Science,1991

5. A 26kd calcium binding protein from bovine rod outer segments as modulator of photoreceptor guanylate cyclase;Lambrecht;EMBO J.,1991

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late-Onset Anti-GABA _B Receptor Encephalitis;Neurology Neuroimmunology & Neuroinflammation;2023-07

2. The probiotic-induced dysregulation of immune-related genes in colon cells and relation with colorectal cancer;Cellular and Molecular Biology;2023-04-30

3. Response of Recoverin-Positive Optic Neuritis to Chemotherapy, Steroid, and Plasma Exchange;Journal of Neuro-Ophthalmology;2022-12-06

4. Neuro-ophthalmic manifestations of cancer: a narrative review;Chinese Clinical Oncology;2022-06

5. The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges;Biomedicines;2022-02-17